AWI delivered solid financial performance with revenue growing 12.1% to $1.6B alongside improved profitability and strengthened cash generation.
The company demonstrated balanced growth with revenue expansion translating effectively to bottom-line results, as net income grew 16.5% to $308.7M while maintaining disciplined expense management. The substantial improvement in operating cash flow to $355.5M and increased cash position to $112.7M suggests strong operational execution and enhanced financial flexibility.
AWI's financial performance reflects a healthy growth trajectory with revenue advancing 12.1% to $1.6B while gross profit expanded 13.3% to $658.7M, indicating improved operational efficiency. Operating income grew 15.1% to $430.9M and net income increased 16.5% to $308.7M, demonstrating effective cost management as SG&A expenses rose only 10%. The balance sheet strengthened notably with cash increasing 42.1% to $112.7M and stockholders' equity growing 19% to $900.7M, while operating cash flow improved 33.2% to $355.5M, signaling robust cash generation capabilities.
Cash position surged 42.1% — strong cash generation or capital raise providing significant financial cushion.
Operating cash flow surged 33.2% — exceptional cash generation, highest quality earnings signal.
Equity base grew 19% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Net income grew 16.5% — bottom-line growth signals improving overall business health.
Operating income improving — cost discipline or growing revenue base absorbing fixed costs.
Inventory built 13.5% — monitor whether demand supports this build or if write-downs may follow.
Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.
Current assets grew 12.2% — improving short-term liquidity or inventory/receivables build.
Revenue growing 12.1% — solid top-line momentum, watch margins for quality of growth.
SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →